US Patent Issued to Merck Sharp & Dohme on Feb. 24 for "Modified imidazopyridines as glucosylceramide synthase inhibitors" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,491, issued on Feb. 24, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Modified imidazopyridines as glucosylceramide synthase inhibitors" was invented by Melissa C. Ford (Sellersville, Pa.), Mark E. Fraley (North Wales, Pa.), Kristen L.G. Jones (Oreland, Pa.), H. Marie Loughran (Perkasie, Pa.), James J. Mulhearn (Elkins, Pa.), Anthony J. Roecker (Harleysville, Pa.), Kathy M. Schirripa (Harleysville, Pa.) and Ling Tong (Warren, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to Compounds of Formula I: I and pharmaceutically acceptable salts or prodrug thereof. The present invention also relates to compositi...